GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,339.00GBp
20 Oct 2014
Price Change (% chg)

-15.50p (-1.14%)
Prev Close
1,354.50p
Open
1,352.00p
Day's High
1,358.00p
Day's Low
1,329.50p
Volume
9,832,193
Avg. Vol
9,644,359
52-wk High
1,709.00p
52-wk Low
1,296.50p

GSK.L

Chart for GSK.L

About

GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK’s principal pharmaceutical products include medicines in... (more)

Overall

Beta: 0.52
Market Cap (Mil.): £65,690.11
Shares Outstanding (Mil.): 4,849.77
Dividend: 19.00
Yield (%): 5.91

Financials

  GSK.L Industry Sector
P/E (TTM): 13.93 32.64 33.19
EPS (TTM): 0.97 -- --
ROI: 18.08 18.40 17.65
ROE: 75.85 19.06 18.46
Search Stocks

GSK says Ebola vaccine development progressing at "unprecedented rate"

LONDON, Oct 18 - Britain's biggest drugmaker GlaxoSmithKline said on Saturday work to develop a vaccine to combat Ebola, which has killed thousands in West Africa, was moving at a rapid pace.

18 Oct 2014

Lundbeck may buy GSK drugs to complement portfolio: Sydbank

COPENHAGEN - Danish pharmaceutical group Lundbeck is one of the potential bidders for some of the older products worth in total $3 billion that British GlaxoSmithKline is looking to divest, according to sources.

15 Oct 2014

Geographic split likely for GSK mature drugs sale: sources

LONDON - GlaxoSmithKline is seeking binding bids by next month for a range of older drugs worth more than $3 billion, which it is likely to sell by geographical region, according to people with direct knowledge of the process.

14 Oct 2014

Geographic split likely for GSK mature drugs sale -sources

LONDON, Oct 14 - GlaxoSmithKline is seeking binding bids by next month for a range of older drugs worth more than $3 billion, which it is likely to sell by geographical region, according to people with direct knowledge of the process.

14 Oct 2014

Mali health workers get experimental GSK vaccine in Ebola trials

BAMAKO - Healthcare workers in Mali have been given an experimental Ebola vaccine as part of the first human trials of the shot in West Africa, where three nations are battling the worst outbreak on record.

10 Oct 2014

Mali health workers get experimental GSK vaccine in Ebola trials

BAMAKO, Oct 10 - Healthcare workers in Mali have been given an experimental Ebola vaccine as part of the first human trials of the shot in West Africa, where three nations are battling the worst outbreak on record.

10 Oct 2014

Deals of the day-Mergers and acquisitions

(Baidu, Lloyds, Serco, Deutsche Boerse, Cytotools, AquaChile, Riverbed, Big Bus Tours)

09 Oct 2014

South Africa's Aspen, GSK team up to extend foothold in Japan

JOHANNESBURG - South Africa generic drugmaker Aspen Pharmacare has teamed up with shareholder GlaxoSmithKline PLC to extend its foothold in Japan, a lucrative market for low-cost medicines, it said on Thursday.

09 Oct 2014

S.Africa's Aspen, GSK team up to extend foothold in Japan

JOHANNESBURG, Oct 9 - South Africa generic drugmaker Aspen Pharmacare has teamed up with shareholder GlaxoSmithKline PLC to extend its foothold in Japan, a lucrative market for low-cost medicines, it said on Thursday.

09 Oct 2014

Novartis says three executives to leave after GSK, Lilly deals

ZURICH - Swiss drugmaker Novartis AG said three members of its executive committee would leave the company following the completion of transactions with GlaxoSmithKline and Eli Lilly to divest three units.

08 Oct 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks